Trails Edge Capital Partners, LP
Trails Edge Capital Partners, LP is an Investment Adviser institutional filer with the SEC under CIK 2077247, reporting 35 portfolio positions, with 8 historical 13F filings on file. Most recent reporting period: 2026-06-30.
A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).
- State of incorporation: DE
- Filing type: 13F-HR
- Latest reporting period: 2026-06-30
- Last filed: 2026-08-14
Top 10 portfolio positions
The largest reported holdings in Trails Edge Capital Partners, LP's most recent 13F filing, ranked by reported market value.
- LB PHARMACEUTICALS INC (LBRX)
- NURIX THERAPEUTICS INC (NRIX)
- IMMUNOCORE HLDGS PLC (IMCR)
- FIRST TRACKS BIOTHERAPEUTICS (TRAX)
- 4D MOLECULAR THERAPEUTICS IN (FDMT)
- BIOMARIN PHARMACEUTICAL INC (BMRN)
- DESIGN THERAPEUTICS INC (DSGN)
- XENON PHARMACEUTICALS INC (XENE)
- MIRUM PHARMACEUTICALS INC (MIRM)
- INSMED INC (INSM)
/